Table 1.
Socio-demographic and clinical characteristics of the study subjects (n = 192)
| Male gender | 122 (63.5) |
|---|---|
| Age, y* |
68.1 (8.5) |
| Employed full time or part-time |
77 (40.1) |
| Post compulsory education or above |
155 (80.7) |
| Married or living with partner |
151 (78.6) |
| Karnofsky Performance status |
|
| 80-100 |
166 (86.5) |
| Comorbid liver disease |
|
| Hepatitis C virus |
126 (65.6) |
| Hepatitis B virus |
38 (19.8) |
| Other or unknown |
28 (14.6) |
| Child-Pugh class |
|
| A |
127 (66.1) |
| B |
53 (27.6) |
| C |
12 (6.3) |
| Cancer stage |
|
| Stage I / II |
161 (83.9) |
| Stage III / IV |
31 (16.1) |
| Time since diagnosis, month* |
39.6 (34.5) |
| Past medical history† |
|
| Hepatectomy |
48 (25.0) |
| Percutaneous ablation |
137 (71.4) |
| Chemoembolization |
64 (33.3) |
| Systemic therapy |
1 (0.5) |
| No medical history | 13 (6.8) |
Values are numbers (%) otherwise specified. * Data was expressed as mean (standard deviation). † Some patients underwent multiple treatments.